Provided by Tiger Trade Technology Pte. Ltd.

Novavax

11.22
-0.1000-0.88%
Post-market: 11.15-0.0666-0.59%18:20 EDT
Volume:8.37M
Turnover:94.98M
Market Cap:1.84B
PE:-7.39
High:11.75
Open:11.01
Low:10.90
Close:11.32
52wk High:13.39
52wk Low:6.20
Shares:164.43M
Float Shares:143.00M
Volume Ratio:0.70
T/O Rate:5.85%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.5181
EPS(LYR):2.58
ROE:-898.20%
ROA:-6.51%
PB:-9.67
PE(LYR):4.35

Loading ...

Novavax Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 22

Novavax Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 18

Novavax Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 17

Novavax Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 15

Mabion Signs Deal with Novavax Expanding Cooperation to Analytical Services for Early-Stage Pipeline Projects

Reuters
·
Sep 14

Mabion Sa - Deal Covers Implementation and Provision of Analytical Services for Novavax's Early-Stage Pipeline Projects

THOMSON REUTERS
·
Sep 14

Mabion Sa - Signs Statement of Work #12 with Novavax to Expand Cooperation Under Existing Manufacturing Agreement

THOMSON REUTERS
·
Sep 14

Novavax Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 12

Novavax Inc. Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Sep 11

Novavax Inc. Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
Sep 10

Novavax Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Sep 05

Novavax Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 03

Novavax to Present at Cantor Global Healthcare Conference in Fireside Chat

Reuters
·
Sep 03

Unusually active option classes on open September 2nd

TIPRANKS
·
Sep 02

Novavax call volume above normal and directionally bullish

TIPRANKS
·
Sep 01

Novavax Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 01

Novavax Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 29

Novavax’s partners approved for Nuvaxovid formulation for vaccination season

TIPRANKS
·
Aug 28

Novavax's Partnership Strategy Continues to Deliver with Xfg-Adapted Nuvaxovid™ Approvals in the U.S., EU and Japan for 2026-2027 Vaccination Season

THOMSON REUTERS
·
Aug 28

Novavax, - Eligible for Royalties on Net Sales in U.S., EU, Japan for 2026-2027 Season

THOMSON REUTERS
·
Aug 28